July 2026
Published Jul 12, 2026RCTs
This study examined the implementation of a mobile health (mHealth) intervention aimed at increasing nonexercise physical activity in patients with Type 2 Diabetes, with unclear effectiveness.
Interventions
mHealth intervention with personal feedback
Outcomes
Acceptability of mHealth interventionFidelity of mHealth interventionPerceived behavior change needs
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effectiveness of a mobile health social support program for diabetes management in emergency department patients, finding significant improvements in HbA1c levels.
Interventions
Peer-support lifestyle program
Outcomes
HbA1cImprovement in glycemic control for newly diagnosed patientsSafety events
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effect of oral semaglutide on heart failure events in patients with type 2 diabetes, finding a reduced risk of composite heart failure outcomes compared to placebo.
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Hyperglycemia eventsHypoglycemia events+1 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026Non-randomized trial
Interventions
Pioglitazone
Outcomes
Adipose tissue elastin contentAdipose tissue macrophage countAdipose tissue mast cell count+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.
Interventions
Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)
Outcomes
Cost-effectiveness assessmentDietary intake changesGestational diabetes mellitus incidence+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
Probiotic supplementation was studied for its effects on glycemic control in pediatric patients with Type 1 Diabetes, showing significant improvements in several metabolic markers.
Interventions
Multispecies probiotic supplementation
Outcomes
Fasting Plasma Glucose (FPG)HbA1cInterleukin-21 levels change+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026Randomized Controlled Trial
This trial tested whether adults with prediabetes could start and maintain resistance training. After a supervised 3-month training phase, about one-third of participants were no longer prediabetic, and this was mostly maintained through 15 months. Extra social-cognitive support did not outperform lower-contact standard care.
Interventions
Behavioral counselingResistance training
Outcomes
2-hour plasma glucoseAdverse events incidenceFasting blood sugar (FBS)+5 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
The study evaluated semaglutide, a glucagon-like peptide-1 receptor agonist, for managing high cardiovascular risk and found significant reductions in major renal events and cardiovascular risks.
Outcomes
All-cause mortalityAnnual rate of change in eGFRCardiovascular events+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
The study evaluated the effects of semaglutide on cardiovascular events in individuals with overweight or obesity and established cardiovascular disease without diabetes, finding a 20% reduction in major adverse cardiovascular events.
Outcomes
All-cause mortalityCardiovascular eventsCardiovascular mortality+8 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the impact of a smartphone-based dietary education intervention on diet quality and cardiometabolic risk markers in individuals with type 2 diabetes, revealing significant reductions in fat intake and triglyceride levels.
Interventions
mHealth dietary education intervention
Outcomes
Daily intake of saturated fat in gramsDaily intake of unsaturated fat in gramsOverall diet quality measured using Nordic Nutrition Recommendation score+1 more
Added to Dediabetes Jul 12, 2026
